People channel feed – Endpoints News

People channel feed

Global CRO Parexel woos outsourcing veteran Jamie Macdonald to the helm

8 years ago

Activist investor Alex Denner in the spotlight again as the Medicines Company shrinks its board

8 years ago

What's up at stealthy Calico Labs? AI star Daphne Koller makes an abrupt exit as top team shrinks

8 years ago

Sentencing date looming, a federal judge's ruling could leave Martin Shkreli in prison for years to come

8 years ago

Novartis’ oncology research chief in China jumps to upstart EpimAb in Shanghai

8 years ago

Vertex CMO Jeffrey Chodakewitz is hitting the exit doors. What's next?

8 years ago

Top Pfizer research exec John Davis joins migration to biotech, lands at Magenta as CMO

8 years ago

Well, that got awkward. Arcturus fires back at ex-CEO Joe Payne

8 years ago

Taking on a big challenge, ex-Celgene CEO Bob Hugin readies a run for the Senate

8 years ago

Ex-FDA commish Califf joins Cytokinetics’ board just months after big ALS flop

8 years ago

David Hung makes a quick, abrupt exit at Axovant after humiliating setbacks

8 years ago

CEO Eliot Forster leaves Immunocore as the UK biotech unicorn hunts cash

8 years ago

Secret meetings, mergers and a board putsch: Arcturus founder/CEO claims 4 board members conspired on his ouster

8 years ago

Hans Bishop gets a $287M payday as Juno execs see windfall fortunes — with a $922M payoff for Arch

8 years ago

RNA biotech Arcturus boots CEO Joseph Payne

8 years ago

Gene therapy pioneer James Wilson sounds an alarm on high-dose AAV studies following toxic reactions in monkeys

8 years ago

Merck R&D chief Roger Perlmutter offers some heavyweight R&D glam to a little upstart biotech out to cure Duchenne MD

8 years ago

After a legendary stint at Celgene's helm, biopharma vet Bob Hugin is on his way out — as Senate race rumors swirl

8 years ago

Heptares co-founder Fiona Marshall grabs the helm at Merck's upcoming UK drug discovery center

8 years ago

Shire CEO Flemming Ornskov is hatching a few new stretch goals for R&D in 2018 — and beyond

8 years ago

Pfizer oncology head Liz Barrett jumps ship to Novartis as Bruno Strigini steps aside

8 years ago

What break? Sarepta vet Ed Kaye quickly pivots to the helm of another biotech upstart with a $40M bankroll

8 years ago

John Mendlein steps in to help focus on the big picture at a fast-growing Moderna

8 years ago

Biogen vet Jean-Paul Kress takes the reins at NYC's Syntimmune

8 years ago

First page Previous page 89 90 919293 94 95 Next page Last page